Company profile
DB · companies + sec_company_profileIncyte Corporation (INCY) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolINCY
- Legal nameIncyte Corporation
- SectorHealthcare
- IndustryBiotechnology
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- CIK0000879169
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$19.36B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG000BNPSQ9
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Pablo J. Cagnoni | President and Global Head of Research & Development | $2.04M | 1963 | — |
| Steven H. Stein | Executive VP, Head of Late-stage Development & Chief Medical Officer | $1.56M | 1967 | — |
| James H. Lee | Group Vice President, Head of Inflammation & AutoImmunity Group | — | — | — |
| Matteo Trotta | Executive VP & GM of Dermatology US | — | 1979 | — |
| Michael James Morrissey | Executive Vice President & Head of Global Technical Operations | — | 1964 | — |
| Pamela Murphy | Vice President of Investor Relations & Corporate Communications | — | 1951 | — |
| Richard A. Hoffman | Executive VP & General Counsel | — | — | — |
| Soni K. Basi | Executive Vice President & Chief Human Resources Officer | — | — | — |